Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT1315 | Individual Protein | Adenosine A1 receptor | Rattus norvegicus | Ki | = | 105000 | nM | 3806581 |
NPT4262 | Individual Protein | Adenosine A2a receptor | Cavia porcellus | Ki | = | 135000 | nM | 3806581 |
NPT4059 | Individual Protein | Adenosine A2b receptor | Homo sapiens | Ki | = | 17300 | nM | 12014951 |
NPT2 | Others | Unspecified | Activity | = | 43 | % | 10411473 | |
NPT4059 | Individual Protein | Adenosine A2b receptor | Homo sapiens | Ki | = | 17300 | nM | 20537438 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 3162.3 | nM | PubChem BioAssay data set |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 4466.8 | nM | PubChem BioAssay data set | ||
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 4256.2 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 67 | nM | PubChem BioAssay data set | |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 461.1 | nM | PubChem BioAssay data set | |
NPT4263 | Tissue | Tissue | Cavia porcellus | Activity | = | 40 | % | 10.1007/s00044-006-0141-7 |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 64.41 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 86.25 | % | 23571415 |
NPT2 | Others | Unspecified | Potency | 29847 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 223.9 | nM | PubChem BioAssay data set | |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 3.2 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 10000 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 13333.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 6309.6 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC109322 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9402 | High Similarity | NPC180493 |
0.9115 | High Similarity | NPC256849 |
0.8947 | High Similarity | NPC303899 |
0.8609 | High Similarity | NPC47936 |
0.8347 | Intermediate Similarity | NPC252603 |
0.8276 | Intermediate Similarity | NPC75131 |
0.8115 | Intermediate Similarity | NPC158847 |
0.8017 | Intermediate Similarity | NPC148385 |
0.7886 | Intermediate Similarity | NPC278549 |
0.7872 | Intermediate Similarity | NPC321052 |
0.7591 | Intermediate Similarity | NPC226184 |
0.7591 | Intermediate Similarity | NPC167285 |
0.7591 | Intermediate Similarity | NPC76544 |
0.75 | Intermediate Similarity | NPC199790 |
0.7395 | Intermediate Similarity | NPC476561 |
0.7213 | Intermediate Similarity | NPC119133 |
0.7131 | Intermediate Similarity | NPC476099 |
0.7123 | Intermediate Similarity | NPC326694 |
0.6992 | Remote Similarity | NPC476562 |
0.6911 | Remote Similarity | NPC10466 |
0.6621 | Remote Similarity | NPC317821 |
0.6615 | Remote Similarity | NPC41958 |
0.6573 | Remote Similarity | NPC320818 |
0.6571 | Remote Similarity | NPC246193 |
0.6552 | Remote Similarity | NPC129756 |
0.6457 | Remote Similarity | NPC476564 |
0.6444 | Remote Similarity | NPC327579 |
0.6439 | Remote Similarity | NPC313547 |
0.6419 | Remote Similarity | NPC229974 |
0.64 | Remote Similarity | NPC189068 |
0.637 | Remote Similarity | NPC33996 |
0.6364 | Remote Similarity | NPC57279 |
0.6358 | Remote Similarity | NPC309832 |
0.6358 | Remote Similarity | NPC219313 |
0.6357 | Remote Similarity | NPC144223 |
0.6349 | Remote Similarity | NPC174114 |
0.6349 | Remote Similarity | NPC87981 |
0.6338 | Remote Similarity | NPC104011 |
0.6333 | Remote Similarity | NPC107374 |
0.6333 | Remote Similarity | NPC156461 |
0.6333 | Remote Similarity | NPC21448 |
0.6331 | Remote Similarity | NPC248007 |
0.6291 | Remote Similarity | NPC164665 |
0.6284 | Remote Similarity | NPC161659 |
0.6284 | Remote Similarity | NPC209525 |
0.6275 | Remote Similarity | NPC136349 |
0.625 | Remote Similarity | NPC269827 |
0.62 | Remote Similarity | NPC314152 |
0.6135 | Remote Similarity | NPC325906 |
0.6115 | Remote Similarity | NPC139776 |
0.609 | Remote Similarity | NPC185991 |
0.609 | Remote Similarity | NPC312187 |
0.609 | Remote Similarity | NPC211025 |
0.609 | Remote Similarity | NPC4837 |
0.609 | Remote Similarity | NPC85689 |
0.6074 | Remote Similarity | NPC324484 |
0.6054 | Remote Similarity | NPC262926 |
0.6051 | Remote Similarity | NPC321814 |
0.6051 | Remote Similarity | NPC472816 |
0.6051 | Remote Similarity | NPC328479 |
0.6051 | Remote Similarity | NPC207633 |
0.6026 | Remote Similarity | NPC150853 |
0.6016 | Remote Similarity | NPC293163 |
0.6014 | Remote Similarity | NPC61198 |
0.6013 | Remote Similarity | NPC212551 |
0.6013 | Remote Similarity | NPC130586 |
0.6013 | Remote Similarity | NPC302778 |
0.6013 | Remote Similarity | NPC164952 |
0.6 | Remote Similarity | NPC121222 |
0.6 | Remote Similarity | NPC59314 |
0.6 | Remote Similarity | NPC239737 |
0.5975 | Remote Similarity | NPC174802 |
0.5964 | Remote Similarity | NPC290959 |
0.5963 | Remote Similarity | NPC195140 |
0.5938 | Remote Similarity | NPC224076 |
0.5938 | Remote Similarity | NPC52238 |
0.5923 | Remote Similarity | NPC273327 |
0.5912 | Remote Similarity | NPC63433 |
0.5901 | Remote Similarity | NPC316618 |
0.5901 | Remote Similarity | NPC226245 |
0.5901 | Remote Similarity | NPC311197 |
0.5901 | Remote Similarity | NPC93365 |
0.5901 | Remote Similarity | NPC54320 |
0.5901 | Remote Similarity | NPC313754 |
0.5886 | Remote Similarity | NPC161224 |
0.5867 | Remote Similarity | NPC470141 |
0.5833 | Remote Similarity | NPC18335 |
0.5828 | Remote Similarity | NPC30326 |
0.5817 | Remote Similarity | NPC186619 |
0.5811 | Remote Similarity | NPC324009 |
0.5806 | Remote Similarity | NPC274384 |
0.5806 | Remote Similarity | NPC89147 |
0.58 | Remote Similarity | NPC470140 |
0.5789 | Remote Similarity | NPC470139 |
0.5782 | Remote Similarity | NPC287876 |
0.5779 | Remote Similarity | NPC74306 |
0.5779 | Remote Similarity | NPC315642 |
0.5772 | Remote Similarity | NPC319221 |
0.5742 | Remote Similarity | NPC251233 |
0.5742 | Remote Similarity | NPC318590 |
0.5742 | Remote Similarity | NPC211820 |
0.5723 | Remote Similarity | NPC323091 |
0.5714 | Remote Similarity | NPC14330 |
0.5705 | Remote Similarity | NPC177169 |
0.5705 | Remote Similarity | NPC317746 |
0.5686 | Remote Similarity | NPC210947 |
0.5669 | Remote Similarity | NPC232408 |
0.5669 | Remote Similarity | NPC64705 |
0.5655 | Remote Similarity | NPC261595 |
0.5649 | Remote Similarity | NPC332382 |
0.5644 | Remote Similarity | NPC472833 |
0.5639 | Remote Similarity | NPC317307 |
0.5638 | Remote Similarity | NPC470138 |
0.5629 | Remote Similarity | NPC126634 |
0.5621 | Remote Similarity | NPC324033 |
0.5621 | Remote Similarity | NPC321458 |
0.5612 | Remote Similarity | NPC327613 |
0.5607 | Remote Similarity | NPC164845 |
0.5606 | Remote Similarity | NPC326248 |
0.5606 | Remote Similarity | NPC187191 |
0.5603 | Remote Similarity | NPC68938 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC109322 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9826 | High Similarity | NPD281 | Approved |
0.9658 | High Similarity | NPD1127 | Approved |
0.9658 | High Similarity | NPD1128 | Approved |
0.9417 | High Similarity | NPD282 | Approved |
0.9402 | High Similarity | NPD9544 | Approved |
0.9402 | High Similarity | NPD78 | Approved |
0.9138 | High Similarity | NPD580 | Discontinued |
0.9115 | High Similarity | NPD9358 | Approved |
0.9115 | High Similarity | NPD9359 | Approved |
0.8983 | High Similarity | NPD2221 | Clinical (unspecified phase) |
0.8898 | High Similarity | NPD9290 | Approved |
0.888 | High Similarity | NPD1119 | Phase 2 |
0.8729 | High Similarity | NPD578 | Discontinued |
0.8661 | High Similarity | NPD535 | Approved |
0.8618 | High Similarity | NPD1775 | Approved |
0.8618 | High Similarity | NPD1085 | Approved |
0.8607 | High Similarity | NPD579 | Clinical (unspecified phase) |
0.8443 | Intermediate Similarity | NPD4262 | Discontinued |
0.8433 | Intermediate Similarity | NPD7531 | Clinical (unspecified phase) |
0.8347 | Intermediate Similarity | NPD76 | Approved |
0.8347 | Intermediate Similarity | NPD9289 | Approved |
0.8347 | Intermediate Similarity | NPD9292 | Approved |
0.8347 | Intermediate Similarity | NPD9288 | Approved |
0.8333 | Intermediate Similarity | NPD2253 | Discontinued |
0.8017 | Intermediate Similarity | NPD9086 | Approved |
0.7868 | Intermediate Similarity | NPD1117 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD1118 | Discontinued |
0.7398 | Intermediate Similarity | NPD8954 | Approved |
0.7398 | Intermediate Similarity | NPD8955 | Approved |
0.7213 | Intermediate Similarity | NPD9291 | Approved |
0.7113 | Intermediate Similarity | NPD2179 | Discontinued |
0.7 | Intermediate Similarity | NPD9360 | Approved |
0.6889 | Remote Similarity | NPD9408 | Phase 3 |
0.6871 | Remote Similarity | NPD4183 | Phase 3 |
0.6871 | Remote Similarity | NPD4182 | Phase 3 |
0.6861 | Remote Similarity | NPD9633 | Phase 3 |
0.6832 | Remote Similarity | NPD4155 | Approved |
0.6744 | Remote Similarity | NPD9373 | Approved |
0.6735 | Remote Similarity | NPD1730 | Discontinued |
0.672 | Remote Similarity | NPD9626 | Clinical (unspecified phase) |
0.6692 | Remote Similarity | NPD307 | Approved |
0.6689 | Remote Similarity | NPD9605 | Phase 3 |
0.6667 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.6645 | Remote Similarity | NPD5321 | Phase 3 |
0.6641 | Remote Similarity | NPD9374 | Approved |
0.6571 | Remote Similarity | NPD248 | Discontinued |
0.6538 | Remote Similarity | NPD9375 | Discontinued |
0.6519 | Remote Similarity | NPD9409 | Discontinued |
0.6493 | Remote Similarity | NPD9606 | Approved |
0.6493 | Remote Similarity | NPD237 | Clinical (unspecified phase) |
0.6486 | Remote Similarity | NPD4240 | Approved |
0.6483 | Remote Similarity | NPD1808 | Phase 1 |
0.6447 | Remote Similarity | NPD3708 | Phase 2 |
0.6444 | Remote Similarity | NPD9607 | Approved |
0.6424 | Remote Similarity | NPD3041 | Approved |
0.6395 | Remote Similarity | NPD3696 | Approved |
0.6395 | Remote Similarity | NPD3695 | Approved |
0.6391 | Remote Similarity | NPD757 | Phase 3 |
0.6345 | Remote Similarity | NPD1120 | Approved |
0.6345 | Remote Similarity | NPD1121 | Approved |
0.6333 | Remote Similarity | NPD249 | Approved |
0.6333 | Remote Similarity | NPD250 | Approved |
0.6331 | Remote Similarity | NPD9084 | Phase 2 |
0.6284 | Remote Similarity | NPD193 | Suspended |
0.6275 | Remote Similarity | NPD548 | Clinical (unspecified phase) |
0.625 | Remote Similarity | NPD186 | Discovery |
0.625 | Remote Similarity | NPD195 | Approved |
0.6242 | Remote Similarity | NPD1017 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD1430 | Approved |
0.6242 | Remote Similarity | NPD3081 | Clinical (unspecified phase) |
0.6242 | Remote Similarity | NPD1431 | Approved |
0.6241 | Remote Similarity | NPD515 | Phase 1 |
0.6225 | Remote Similarity | NPD7158 | Phase 1 |
0.62 | Remote Similarity | NPD185 | Approved |
0.6148 | Remote Similarity | NPD9584 | Phase 2 |
0.6138 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.6138 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.6135 | Remote Similarity | NPD1777 | Approved |
0.6135 | Remote Similarity | NPD1776 | Approved |
0.6118 | Remote Similarity | NPD166 | Approved |
0.6115 | Remote Similarity | NPD3107 | Discontinued |
0.6111 | Remote Similarity | NPD9632 | Phase 3 |
0.609 | Remote Similarity | NPD283 | Approved |
0.6056 | Remote Similarity | NPD4812 | Phase 1 |
0.6054 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6014 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.6013 | Remote Similarity | NPD214 | Approved |
0.6013 | Remote Similarity | NPD213 | Clinical (unspecified phase) |
0.6013 | Remote Similarity | NPD338 | Approved |
0.6013 | Remote Similarity | NPD1369 | Phase 2 |
0.6013 | Remote Similarity | NPD242 | Approved |
0.6013 | Remote Similarity | NPD1750 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD2624 | Phase 2 |
0.6 | Remote Similarity | NPD1250 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD2646 | Discontinued |
0.6 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.5975 | Remote Similarity | NPD339 | Approved |
0.596 | Remote Similarity | NPD549 | Approved |
0.5951 | Remote Similarity | NPD3083 | Approved |
0.5942 | Remote Similarity | NPD1368 | Approved |
0.5938 | Remote Similarity | NPD169 | Phase 2 |
0.5917 | Remote Similarity | NPD5666 | Phase 2 |
0.5915 | Remote Similarity | NPD798 | Discontinued |
0.5909 | Remote Similarity | NPD171 | Discontinued |
0.5901 | Remote Similarity | NPD219 | Phase 3 |
0.5901 | Remote Similarity | NPD216 | Approved |
0.5901 | Remote Similarity | NPD220 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD546 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD1732 | Phase 3 |
0.5901 | Remote Similarity | NPD217 | Approved |
0.5901 | Remote Similarity | NPD218 | Approved |
0.5896 | Remote Similarity | NPD613 | Phase 2 |
0.5886 | Remote Similarity | NPD7842 | Phase 2 |
0.5878 | Remote Similarity | NPD9083 | Clinical (unspecified phase) |
0.5878 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.5865 | Remote Similarity | NPD1816 | Clinical (unspecified phase) |
0.5833 | Remote Similarity | NPD8836 | Approved |
0.5806 | Remote Similarity | NPD9627 | Approved |
0.5802 | Remote Similarity | NPD2604 | Approved |
0.5793 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.5782 | Remote Similarity | NPD8829 | Clinical (unspecified phase) |
0.5779 | Remote Similarity | NPD582 | Approved |
0.5775 | Remote Similarity | NPD1790 | Clinical (unspecified phase) |
0.5762 | Remote Similarity | NPD6112 | Approved |
0.5762 | Remote Similarity | NPD2602 | Clinical (unspecified phase) |
0.5753 | Remote Similarity | NPD2191 | Discontinued |
0.575 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.5714 | Remote Similarity | NPD9195 | Approved |
0.5703 | Remote Similarity | NPD9189 | Discontinued |
0.5696 | Remote Similarity | NPD775 | Approved |
0.5678 | Remote Similarity | NPD3043 | Approved |
0.5678 | Remote Similarity | NPD3042 | Approved |
0.5676 | Remote Similarity | NPD1705 | Discontinued |
0.5674 | Remote Similarity | NPD8824 | Phase 3 |
0.5667 | Remote Similarity | NPD1058 | Discontinued |
0.5655 | Remote Similarity | NPD247 | Clinical (unspecified phase) |
0.5649 | Remote Similarity | NPD9135 | Approved |
0.5649 | Remote Similarity | NPD9134 | Approved |
0.5649 | Remote Similarity | NPD9255 | Phase 2 |
0.5639 | Remote Similarity | NPD9629 | Approved |
0.5629 | Remote Similarity | NPD9484 | Clinical (unspecified phase) |
0.5621 | Remote Similarity | NPD2647 | Phase 3 |
0.5617 | Remote Similarity | NPD1731 | Clinical (unspecified phase) |
0.5612 | Remote Similarity | NPD1623 | Approved |
Molecular Weight:   | 224.09 |
ALogP:   | -0.9705 |
MLogP:   | 1.68 |
XLogP:   | -1.334 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 78.67 |
# H-Bond Aceptor:   | 7 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 16 |